Evergreen Bancorp Inc (Del) | TalkMarkets

Latest Posts

Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries

Article By: Alan Sumler

Thursday, April 27, 2023 9:33 AM EDT

Evogene employs an AI platform for decoding plant phenotypes and microbial genomes. The set-up may present a long-tern investment strategy.

In this article: EVGN Also: CTVA, BAYRY, DNA, SDGR, RLAY

Read

Biomica Announces Closing Of $20 Million Financing Round Led By Shanghai Healthcare Capital

Article By: TalkMarkets Newswire

Thursday, April 27, 2023 8:00 AM EDT

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it has closed a financing round of $20 million

In this article: EVGN

Read

Evogene Offers An Excellent Risk/Reward Ratio

Article By: Shareholders Unite

Wednesday, March 22, 2023 9:35 AM EDT

We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine.

In this article: EVGN Also: SDGR, EXAI, RLAY, DNA, CTVA, BAYRY

Read

7 Disruptive Innovation Stocks - Price Technical Analysis

Video By: Peter Mathers

Sunday, October 11, 2020 9:28 PM EDT

I'm looking at the price technicals for these US Stocks: Deere & Co, Docusign, Editas Medicine, Elbit Systems, Evogene, Faro Technologies, and Fate Therapeutics.

In this video: DE, ESLT, EVGN, EDIT, DOCU, FARO, FATE

Watch

TA For 7 US Stocks: DE, DOCU, EDIT, ESLT, EVGN, FARO, FATE

Video By: Peter Mathers

Sunday, September 6, 2020 7:30 PM EDT

Price technical analysis, Elliott Wave and trading levels for Deere, Docusign, Editas, Elbit Systems, Evogene, Faro Technologies and Fate Therapeutics

In this video: DE, FARO, ESLT, EVGN, FATE, EDIT, DOCU

Watch

All Posts